SCHEMBL3715216

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL13019817	0.85	SRC (0.73)	SRCABL1KDREGFRBTK
	SCHEMBL13019824	0.85	SRC (0.71)	SRCABL1KDREGFRBTK
	SCHEMBL14617301	0.83	SRC (0.89)	SRCABL1KDREGFRBTK
	SCHEMBL13019823	0.83	SRC (0.74)	SRCABL1KDREGFRBTK
	SCHEMBL407934	0.81	SRC (1.00)	SRCABL1KDREGFRBTK
	SCHEMBL29432587	0.81	SRC (1.00)	SRCABL1KDREGFRBTK
	SCHEMBL5620074	0.80	SRC (0.78)	SRCABL1KDREGFRBTK
	SCHEMBL409444	0.80	SRC (0.82)	SRCABL1KDREGFRBTK
	SCHEMBL12436458	0.80	RET (0.63)	SRCABL1KDREGFRBTK
	SCHEMBL13019805	0.79	SRC (0.73)	SRCABL1KDREGFRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.